A50 — Thomson Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual income statement for Thomson Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	R2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IFRS	IFRS	IFRS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	240	334	356	351	395
Cost of Revenue
Gross Profit	191	278	296	275	295
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	192	242	274	278	379
Operating Profit	48.8	91.8	82.3	73.5	15.9
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26.2	69.3	55.2	29.2	-40.6
Provision for Income Taxes
Net Income After Taxes	16.9	58.6	41.1	18.2	-47
Minority Interest
Net Income Before Extraordinary Items
Net Income	14.2	53.8	36.6	14.2	-47.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14.2	53.8	36.6	14.2	-47.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.001	0.002	0.001	-0	-0.001
Dividends per Share